Profil
Jessica Lifton is currently the Director at Shanghai ShouTi Biotechnology Co. Ltd. She previously worked as the Director at Aro Biotherapeutics Co. from 2020 to 2022.
Additionally, she served as an Independent Director at Structure Therapeutics, Inc. Ms. Lifton completed her undergraduate degree at Union College (New York).
Aktive Positionen von Jessica Lifton
| Unternehmen | Position | Beginn |
|---|---|---|
Shanghai ShouTi Biotechnology Co., Ltd.
Shanghai ShouTi Biotechnology Co., Ltd. BiotechnologyHealth Technology Develops biotechnologies | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Jessica Lifton
| Unternehmen | Position | Ende |
|---|---|---|
Aro Biotherapeutics Co.
Aro Biotherapeutics Co. BiotechnologyHealth Technology Operates as a biotechnology company which focuses on the research and development of a new generation of protein biologics | Direktor/Vorstandsmitglied | 01.12.2022 |
| STRUCTURE THERAPEUTICS INC. | Direktor/Vorstandsmitglied | - |
Ausbildung von Jessica Lifton
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Union College (New York)
Union College (New York) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aro Biotherapeutics Co.
Aro Biotherapeutics Co. BiotechnologyHealth Technology Operates as a biotechnology company which focuses on the research and development of a new generation of protein biologics | Health Technology |
Structure Therapeutics, Inc.
Structure Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops molecule therapeutics to treat chronic diseases | Health Technology |
Shanghai ShouTi Biotechnology Co., Ltd.
Shanghai ShouTi Biotechnology Co., Ltd. BiotechnologyHealth Technology Develops biotechnologies | Health Technology |
















